Best Castleman Disease Hospitals in Israel

At Rabin Medical Center, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 1996, the JCI accredited hospital is located in Petah Tikva, Israel, and has 1300 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.

Sheba Medical Center offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 1948, the JCI accredited hospital is located in Ramat Gan, Israel, with 1900 beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

Herzliya Medical Center offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 1983, the accredited hospital is situated in Herzliya, Israel, with 120 beds, serving local and international patients.

Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.

Assuta Hospital offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 1934, the JCI accredited hospital is situated in Tel Aviv, Israel, with 300 beds, serving local and international patients.

Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.

Tel Aviv Sourasky Medical Center -Ichilov Hospital provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1963, the JCI accredited hospital is based in Tel Aviv, Israel, with 1500 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.